trending Market Intelligence /marketintelligence/en/news-insights/trending/znvsiuig89ad5wvc2danlq2 content esgSubNav
In This List

Pain Therapeutics fails to maintain $50M in market cap; Nasdaq sends notice

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Pain Therapeutics fails to maintain $50M in market cap; Nasdaq sends notice

Pain Therapeutics, Inc. said it received a non-compliance notice from Nasdaq for failing to maintain a market value of at least $50 million.

The Austin, Texas-based company also falls short of the total assets and total revenue requirements to remain listed on the Nasdaq Global Market and has until Sept. 10 to regain compliance.

Pain Therapeutics, which develops treatments for pain, said it will monitor the market value of its stock and take actions as necessary. The company's stock price stood at $7.15 per share as of market close on March 16.